Exhibit 107

 

Calculation of Filing Fee Tables

 

424(b)(5)

 

(Form Type)

 

Mind Medicine (MindMed) Inc. 

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 

    Security
  Type		  

Security

Class Title

  

Fee

Calculation

or Carry
Forward

Rule

  

Amount

Registered

  

Proposed

Maximum

Offering

Price

Per Unit

  

Maximum

Aggregate

Offering

Price

    

Fee

Rate

    

Amount of

Registration

Fee (1)

  
Newly Registered Securities

Fees to Be

Paid

   Equity   

Common Shares,

without

par value

   Rule 457(r)   10,714,286 (2)   $7.00   $75,000,002       0.0001476     $11,070  

Fees to Be

Paid

   Equity   

Pre-funded warrants

to purchase

common shares

   Rule 457(r)   1,428,775   $7.00(3)    —(3)       0.0001476     —(3)  
Fees
Previously
Paid		   N/A   N/A   N/A   N/A   N/A   N/A             N/A  
Carry Forward Securities
Carry
Forward
Securities		   N/A   N/A   N/A   N/A       N/A                
    Total Offering Amounts        $75,000,002             $11,070  
    Total Fees Previously Paid                      —  
    Total Fee Offsets                      —  
    Net Fee Due                      $11,070  

 

(1) Calculated in accordance with Rule 457(r) under the Securities Act of 1933, as amended (the “Securities Act”). In accordance with Rules 456(b) and 457(r) under the Securities Act, the registrant initially deferred payment of all of the registration fees for the Registration Statement on Form S-3 (Registration No. 333-280548), filed on June 28, 2024, other than in connection with $150,000,000 of common shares of the Company that may be issued and sold from time to time under the prospectus supplement included therein.
(2) Includes 1,428,775 common shares that are issuable upon the exercise of the pre-funded warrants referenced below.

(3) Represents the sum of the public offering price of the pre-funded warrants of $6.999 per pre-funded warrant and the exercise price of $0.001 per share issuable pursuant to the pre-funded warrants. Pursuant to Securities and Exchange Commission staff interpretation, the entire fee is allocated to the common shares underlying the pre-funded warrants.